The effect of oral contraceptive use on sympatic nerve activity in patients with polycystic ovary syndrome

References

• Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333(13):853–861.
   PubMed Web of Science ®Google Scholar
• Norman RJ, Dewailly D, Legro RS, et al. Polycystic ovary syndrome. Lancet. 2007;370(9588):685–697.
   PubMed Web of Science ®Google Scholar
• Carmina E, Koyama T, Chang L, et al. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol. 1992;167(6):1807–1812.
   PubMed Web of Science ®Google Scholar
• DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. 2005;83(5):1454–1460.
   PubMed Web of Science ®Google Scholar
• Legro RS, Kunselman AR, Dodson WC, et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol. Metab. 1999;84(1):165–169.
   PubMed Web of Science ®Google Scholar
• Aguado LI. Role of the central and peripheral nervous system in the ovarian function. Microsc Res Tech. 2002;59(6):462–473.
   PubMedGoogle Scholar
• Yildirir A, Aybar F, Kabakci G, et al. Heart rate variability in young women with polycystic ovary syndrome. Ann Noninv Electrocard. 2006;11(4):306–312.
   PubMed Web of Science ®Google Scholar
• Di Domenico K, Wiltgen D, Nickel FJ, et al. Cardiac autonomic modulation in polycystic ovary syndrome: does the phenotype matter? Fertil Steril. 2013;99(1):286–292.
   PubMed Web of Science ®Google Scholar
• Lansdown A, Rees DA. The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target? Clin Endocrinol. 2012;77(6):791–801.
   PubMed Web of Science ®Google Scholar
• Straznicky NE, Grima MT, Eikelis N. et al. The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components. J Clin Endocrinol Metab. 2011;96(3):503–508.
   PubMed Web of Science ®Google Scholar
• Stener-Victorin E, Jedel E, Janson PO, et al. Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome. AJP Regul Integr Comp Physiol. 2009;297(2):387–395.
   Google Scholar
• Jedel E, Labrie F, Odén A. Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial. Am J Physiol Endocrinol Metab. 2011;300:37–45.
   PubMed Web of Science ®Google Scholar
• Tasali E, Chapotot F, Leproult R, et al. Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2011;96(2):365–374.
   PubMedGoogle Scholar
• Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6(1):1–13.
   PubMedGoogle Scholar
• Baird DT, Collins J, Egozcue J, et al. Noncontraceptive health benefits of combined oral contraception. Hum Reprod Update. 2005;11(5):513–525.
   PubMedGoogle Scholar
• Grimes DA, Economy KE. Primary prevention of gynecologic cancers. Am J Obstet Gynecol. 1995;172(1):227–235.
   PubMedGoogle Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–47.
   PubMed Web of Science ®Google Scholar
• Valsamakis G, Chetty R, Anwar A, et al. Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and Indo-Asian subjects. Diabet Med. 2004;21(12):1339–1345.
   PubMedGoogle Scholar
• Cook H, Brennan K, Azziz R. Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism? Fertil Steril. 2011;96(5):1266–1270.
   PubMedGoogle Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666–3672.
   PubMed Web of Science ®Google Scholar
• Hashim ZH, Hamdan FB, Al-Salihi AR. Autonomic dysfunction in women with polycystic ovary syndrome. Iran J Reprod Med. 2015;13(1):27–34.
   PubMedGoogle Scholar
• Kilit C, Paşalı Kilit T. Heart rate variability in normal-weight patients with polycystic ovary syndrome. Anatol J Cardiol. 2017;17(5):404–409.
   PubMedGoogle Scholar
• Lyu RK, Tang LM, Hsu WC, et al. Quantitative cardiovascular autonomic function study in fisher syndrome. J Neurol Neurosurg Psychiatry. 2002;73(3):333–335.
   PubMedGoogle Scholar
• Diamanti-Kandarakis E, Spina G, Kouli C, et al. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy. J Clin Endocrinol Metab. 2001;86(10):4666–4673.
   PubMed Web of Science ®Google Scholar
• Minozzi M, Costantino D, Guaraldi C, et al. The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome. Gynecol Endocrinol. 2011;27(11):920–924.
   PubMed Web of Science ®Google Scholar
• Okyay E, Gode F, Acet F, et al. The effect of drospirenone (3 mg) with ethinyl estradiol (30 mcg) containing pills on ovarian blood flows in women with polycystic ovary syndrome: a case controlled study. Eur J Obstet Gynecol Reprod Biol. 2014;180(1):93–99.
   PubMedGoogle Scholar
• Golland IM, Elstein ME. Results of an open one-year study with Diane-35 in women with polycystic ovarian syndrome. Ann N Y Acad Sci. 1993;687(1):263–271.
   PubMedGoogle Scholar
• Nobels F, Dewailly D. Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis. Fertil Steril. 1992;58(4):655–666.
   PubMed Web of Science ®Google Scholar
• Falsetti L, Gambera A, Tisi G. Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome. Hum. Reprod. 2001;16(1):36–42.
   PubMed Web of Science ®Google Scholar